These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 8930364)
1. kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids. Gurwell JA; Duncan MJ; Maderspach K; Stiene-Martin A; Elde RP; Hauser KF Brain Res; 1996 Oct; 737(1-2):175-87. PubMed ID: 8930364 [TBL] [Abstract][Full Text] [Related]
2. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Stiene-Martin A; Zhou R; Hauser KF Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211 [TBL] [Abstract][Full Text] [Related]
3. mu-Opioid receptor-induced Ca2+ mobilization and astroglial development: morphine inhibits DNA synthesis and stimulates cellular hypertrophy through a Ca(2+)-dependent mechanism. Hauser KF; Stiene-Martin A; Mattson MP; Elde RP; Ryan SE; Godleske CC Brain Res; 1996 May; 720(1-2):191-203. PubMed ID: 8782912 [TBL] [Abstract][Full Text] [Related]
4. Opioids disrupt Ca2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: transient increases and adaptation to sustained exposure. Hauser KF; Harris-White ME; Jackson JA; Opanashuk LA; Carney JM Exp Neurol; 1998 May; 151(1):70-6. PubMed ID: 9582255 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart. Zhang WM; Wang HX; Xia Q; Wong TM Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688 [TBL] [Abstract][Full Text] [Related]
6. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442 [TBL] [Abstract][Full Text] [Related]
7. Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro. Stiene-Martin A; Hauser KF J Neurosci Res; 1991 Aug; 29(4):538-48. PubMed ID: 1665190 [TBL] [Abstract][Full Text] [Related]
8. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394 [TBL] [Abstract][Full Text] [Related]
9. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro. Feng J; Kendig JJ Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192 [TBL] [Abstract][Full Text] [Related]
11. Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons. Moises HC; Rusin KI; Macdonald RL J Neurosci; 1994 Oct; 14(10):5903-16. PubMed ID: 7931552 [TBL] [Abstract][Full Text] [Related]
12. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats. Gullapalli S; Ramarao P Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518 [TBL] [Abstract][Full Text] [Related]
13. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine. Powell KR; Holtzman SG Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921 [TBL] [Abstract][Full Text] [Related]
14. Kappa-opioid receptors on astrocytes stimulate L-type Ca2+ channels. Eriksson PS; Nilsson M; Wågberg M; Hansson E; Rönnbäck L Neuroscience; 1993 May; 54(2):401-7. PubMed ID: 8393154 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory activity of mu- and kappa-selective opioid agonists. Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441 [TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice. Horan P; de Costa BR; Rice KC; Porreca F J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325 [TBL] [Abstract][Full Text] [Related]
17. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B). Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804 [TBL] [Abstract][Full Text] [Related]
18. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. Joseph DB; Bidlack JM J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351 [TBL] [Abstract][Full Text] [Related]
19. Differential agonist regulation of the human kappa-opioid receptor. Blake AD; Bot G; Li S; Freeman JC; Reisine T J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509 [TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP regulates the calcium transients released from IP(3)-sensitive stores by activation of rat kappa-opioid receptors expressed in CHO cells. Ikeda M; Nelson CS; Shinagawa H; Shinoe T; Sugiyama T; Allen CN; Grandy DK; Yoshioka T Cell Calcium; 2001 Jan; 29(1):39-48. PubMed ID: 11133354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]